wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50655554-4D8E252B-DAF4-4142-885C-69B83C9E058C
Q50655554-4D8E252B-DAF4-4142-885C-69B83C9E058C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50655554-4D8E252B-DAF4-4142-885C-69B83C9E058C
Zinc oxide nanoparticles antagonize the effect of Cetuximab on head and neck squamous cell carcinoma in vitro.
P2860
Q50655554-4D8E252B-DAF4-4142-885C-69B83C9E058C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50655554-4D8E252B-DAF4-4142-885C-69B83C9E058C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77b52e696f46e914eaec1f78ecc170995a07ffe1
P2860
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.